These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 6741429

  • 41. Signet-ring plasma cell myeloma.
    Grier DD, Robbins K.
    Am J Hematol; 2012 Jun; 87(6):625. PubMed ID: 21953819
    [No Abstract] [Full Text] [Related]

  • 42. BCL-X expression in multiple myeloma: possible indicator of chemoresistance.
    Tu Y, Renner S, Xu F, Fleishman A, Taylor J, Weisz J, Vescio R, Rettig M, Berenson J, Krajewski S, Reed JC, Lichtenstein A.
    Cancer Res; 1998 Jan 15; 58(2):256-62. PubMed ID: 9443402
    [Abstract] [Full Text] [Related]

  • 43. Multiple myeloma and secondary plasma cell leukemia.
    Dos Santos VM, Melim SP, de Faria PS, Passini VV, Duarte ML, Casasanta RA.
    Rom J Morphol Embryol; 2016 Jan 15; 57(2 Suppl):837-839. PubMed ID: 27833979
    [Abstract] [Full Text] [Related]

  • 44. [Plasma cell leukemias].
    Bullorsky EO, Venditti J, Shanley C, Rabinovich O, Lajous JR.
    Medicina (B Aires); 1987 Jan 15; 47(4):399-402. PubMed ID: 3452731
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Multiple myeloma with two rate complications.
    Chugh SN, Girdhar NK, Chopra JS, Singh U, Mahajan SK, Malhotra KC.
    J Indian Med Assoc; 1988 Sep 15; 86(9):246-8. PubMed ID: 3235845
    [No Abstract] [Full Text] [Related]

  • 47. Plasma cell leukemia with myelofibrosis.
    Kasahara S, Tsurumi H, Yoshikawa T, Hara T, Shimizu M, Oyama M, Moriwaki H.
    J Clin Exp Hematop; 2008 Nov 15; 48(2):71-3. PubMed ID: 19039200
    [No Abstract] [Full Text] [Related]

  • 48. Interleukin-6 dependence of advanced malignant plasma cell dyscrasias.
    Zhang XG, Bataille R, Widjenes J, Klein B.
    Cancer; 1992 Mar 15; 69(6):1373-6. PubMed ID: 1540875
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Nuclear lobulation and cytoplasmic fibrils in leukemic plasma cells.
    Beltran G, Stuckey WJ.
    Am J Clin Pathol; 1972 Aug 15; 58(2):159-64. PubMed ID: 4114839
    [No Abstract] [Full Text] [Related]

  • 53. Plasma cell leukemia with myelofibrosis.
    Murayama T, Matsui T, Hayashi Y, Taniguchi T, Ito M, Natazuka T, Imoto S, Iwata N, Isobe T, Ito H.
    Ann Hematol; 1994 Sep 15; 69(3):151-2. PubMed ID: 8086511
    [Abstract] [Full Text] [Related]

  • 54. [Research Progress on Multiple Myeloma with Extramedullary Disease].
    Wang L, Zhang YZ.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun 15; 24(3):945-8. PubMed ID: 27342539
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Proliferation kinetics of plasma cells and of normal haemopoietic cells in multiple myeloma.
    Ucci G, Riccardi A, Dörmer P, Danova M, Luoni R, Montecucco CM, Ciotti R, Girino M.
    Cell Tissue Kinet; 1987 May 15; 20(3):311-8. PubMed ID: 3480077
    [Abstract] [Full Text] [Related]

  • 58. The incidence of phagocytizing plasma cells in malignant plasma cell dyscrasias.
    Kanoh T, Fujii H.
    Scand J Haematol; 1986 May 15; 36(5):480-3. PubMed ID: 3738429
    [Abstract] [Full Text] [Related]

  • 59. Plasma cell leukemia: Clinicopathologic, immunophenotypic and cytogenetic characteristics of 4 cases.
    Alghasham N, Alnounou R, Alzahrani H, Alsharif F.
    Hematol Oncol Stem Cell Ther; 2015 Jun 15; 8(2):71-7. PubMed ID: 25929729
    [Abstract] [Full Text] [Related]

  • 60. Plasmablastic multiple myeloma with Dutcher bodies.
    Jain D, Singh T.
    Indian J Pathol Microbiol; 2008 Jun 15; 51(3):442-3. PubMed ID: 18723987
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.